- Home
- BPYPO vs ORMP Comparison
BPYPO vs ORMP Comparison
Compare BPYPO & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BPYPO | ORMP |
|---|---|---|
| Founded | N/A | 2002 |
| Country | Bermuda | United States |
| Employees | 30200 | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 117.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BPYPO | ORMP |
|---|---|---|
| Price | $14.75 | $2.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | ★ 162.7K |
| Earning Date | N/A | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 838.25 |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.83 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | N/A | $1.82 |
| 52 Week High | N/A | $3.24 |
Technical Indicators
Market Signals| Indicator | BPYPO | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 55.43 | 53.32 |
| Support Level | $14.28 | $2.75 |
| Resistance Level | $14.85 | $3.24 |
| Average True Range (ATR) | 0.23 | 0.15 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 77.05 | 29.48 |
Price Performance
Historical ComparisonAbout BPYPO Brookfield Property Partners L.P.
Brookfield Property Partners LP owns, operates, and invests in commercial properties in North America, Europe, Australia, and Brazil. The company focuses on being an owner and operator of real estate, providing investors with diversified exposure to some of the iconic properties and acquiring high-quality assets at a discount to replacement cost or intrinsic value. Its operating segment includes Core Office, Core Retail, LP Investments, and Corporate Segments. The company operates in various sectors such as the office sector, retail sector, industrial, multifamily, hospitality, triple net lease, and corporate sector. It generates a majority of revenue from the LP Investments segment.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.